|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Histoplasma Antibody, Complement Fixation, CSF
Test Code5297
CPT Codes
86698 (x2)
Includes
Yeast Phase Antibody and Mycelial Phase Antibody
Preferred Specimen
1 mL CSF collected in a sterile, leak-proof container
Minimum Volume
0.5 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly icteric
Methodology
Complement Fixation (CF)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sat; Report available: 2-5 days
Reference Range
Yeast Phase Antibody | <1:1 titer |
Mycelial Phase Antibody | <1:1 titer |
Interpretive Criteria
<1:1 | Antibody Not Detected |
≥1:1 | Antibody Detected |
Clinical Significance
Central nervous system infection occurs in up to 25% of patients with subacute progressive disseminated histoplasmosis. Detection of antibodies in CSF can serve as a useful tool for identifying these patients.